Daniel J Vis

3PUBLICATIONS
37CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Sep 17, 2026
Pre-existing immunity and hrHPV status determine immunotherapy response in advanced penile cancer: biomarkers and overall survival in the PERICLES trial.

|Jun 09, 2025
Biomarker Analysis and Treatment Dynamics Following Preoperative Ipilimumab plus Nivolumab in Locally Advanced Urothelial Cancer from the Phase IB NABUCCO Study.

Chantal F Stockem, Alberto Gil-Jimenez, Hamza Ali

|Jul 24, 2024
Platinum-Based Chemotherapy Induces Opposing Effects on Immunotherapy Response-Related Spatial and Stromal Biomarkers in the Bladder Cancer Microenvironment.

Maksim A Chelushkin, Jeroen van Dorp, Sandra van Wilpe

Pageof 1

Frequent Collaborators

3 joint publications

Lodewyk F A Wessels

3 joint publications

Iris M Seignette

3 joint publications

Annegien Broeks

3 joint publications

Alberto Gil-Jimenez